SCHEMBL3348378

SCHEMBL3348378

CC(C)N1CCC(c2cn(C)c3ccc(N)cc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.49
SLC6A4 P31645 2/20 0.49
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43
RORC P51449 14/20 0.39
PRKCG P05129 1/20 0.37
PRKCB P05771 1/20 0.37
PRKCA P17252 1/20 0.37
PRKCH P24723 1/20 0.37
PRKCE Q02156 1/20 0.37
PRKCZ Q05513 1/20 0.37
PRKCD Q05655 1/20 0.37
CAMK2B Q13554 1/20 0.37
CAMK2G Q13555 1/20 0.37
CAMK2D Q13557 1/20 0.37
CAMK2A Q9UQM7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24188509 0.86 SLC6A4 (0.40) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL3352752 0.86 HTR1B (0.57) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL3352861 0.84 DRD2 (0.55) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL17060397 0.83 DRD2 (0.49) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL3351361 0.83 DRD2 (0.50) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL17060402 0.82 DRD2 (0.48) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL3355377 0.82 DRD2 (0.62) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL3353028 0.80 RORC (0.48) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL17495546 0.80 RORC (0.50) DRD2SLC6A4HTR1DHTR1BRORC
SCHEMBL26630179 0.78 DRD2 (0.48) DRD2SLC6A4HTR1DHTR1BRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed